Investor Presentation
Asgard Alcobev H1FY27 Investor Presentation
Asgard Alcobev shared its H1FY27 and Q2FY27 investor presentation, reporting revenue growth, improved margins, higher utilisation and plans to expand capacity to 10.8 million cases by March 2027.




